APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Receptor Radionuclide Therapy (PRRT)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025182 pages

Choose your research edition.

Industry ResearchPeptide Receptor Radionuclide Therapy (PRRT) Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Receptor Radionuclide Therapy (PRRT) Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Peptide Receptor Radionuclide Therapy (PRRT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Receptor Radionuclide Therapy (PRRT) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Receptor Radionuclide Therapy (PRRT) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Peptide Receptor Radionuclide Therapy (PRRT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peptide Receptor Radionuclide Therapy (PRRT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide Receptor Radionuclide Therapy (PRRT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Receptor Radionuclide Therapy (PRRT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptide Receptor Radionuclide Therapy (PRRT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide Receptor Radionuclide Therapy (PRRT) include Aurobindo Pharma, Curium Pharmaceuticals, Lantheus, Mundipharma, Bayer and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peptide Receptor Radionuclide Therapy (PRRT) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide Receptor Radionuclide Therapy (PRRT) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide Receptor Radionuclide Therapy (PRRT) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide Receptor Radionuclide Therapy (PRRT) market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide Receptor Radionuclide Therapy (PRRT) Segment by Company

Aurobindo Pharma

Curium Pharmaceuticals

Lantheus

Mundipharma

Bayer

Novartis

Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type

Midgut Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor

Foregut Neuroendocrine Tumor

Hindgut Neuroendocrine Tumor

Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Peptide Receptor Radionuclide Therapy (PRRT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Receptor Radionuclide Therapy (PRRT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Receptor Radionuclide Therapy (PRRT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Receptor Radionuclide Therapy (PRRT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide Receptor Radionuclide Therapy (PRRT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Receptor Radionuclide Therapy (PRRT) industry.

Chapter 3: Detailed analysis of Peptide Receptor Radionuclide Therapy (PRRT) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Receptor Radionuclide Therapy (PRRT)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Midgut Neuroendocrine Tumor Table 3. Key Players of Gastroenteropancreatic Neuroendocrine Tumor Table 4. Key Players of Foregut Neuroendocrine Tumor Table 3. Key Players of Hindgut Neuroendocrine Tumor Table 4. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2021-2026) Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2027-2032) Table 13. Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Industry Drivers Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Industry Opportunities and Challenges Table 16. Peptide Receptor Radionuclide Therapy (PRRT) Industry Restraints Table 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Company (2021-2026) Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Peptide Receptor Radionuclide Therapy (PRRT) Key Company Head Office and Area Served Table 21. Global Peptide Receptor Radionuclide Therapy (PRRT) Company, Product Type & Application Table 22. Global Peptide Receptor Radionuclide Therapy (PRRT) Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Peptide Receptor Radionuclide Therapy (PRRT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2021-2026) Table 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2027-2032) Table 30. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2021-2026) Table 34. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2027-2032) Table 35. Aurobindo Pharma Company Information Table 36. Aurobindo Pharma Business Overview Table 37. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 39. Aurobindo Pharma Recent Development Table 40. Curium Pharmaceuticals Company Information Table 41. Curium Pharmaceuticals Business Overview Table 42. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 44. Curium Pharmaceuticals Recent Development Table 45. Lantheus Company Information Table 46. Lantheus Business Overview Table 47. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 49. Lantheus Recent Development Table 50. Mundipharma Company Information Table 51. Mundipharma Business Overview Table 52. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 54. Mundipharma Recent Development Table 55. Bayer Company Information Table 56. Bayer Business Overview Table 57. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 59. Bayer Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio Table 64. Novartis Recent Development Table 65. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026) Table 71. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032) Table 72. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026) Table 78. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032) Table 79. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 80. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 81. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 82. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026) Table 89. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Product Image Figure 2. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type: 2025 VS 2032 Figure 4. Midgut Neuroendocrine Tumor Image Figure 5. Gastroenteropancreatic Neuroendocrine Tumor Image Figure 6. Foregut Neuroendocrine Tumor Image Figure 7. Hindgut Neuroendocrine Tumor Image Figure 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2025 VS 2032 Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2021-2032) Figure 22. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2021-2032) Figure 24. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 25. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032) Figure 26. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032) Figure 27. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032) Figure 28. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 29. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 32. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032) Figure 33. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032) Figure 34. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032) Figure 35. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 36. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 38. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 39. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 41. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 42. China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032) Figure 43. China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032) Figure 44. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 45. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032) Figure 46. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032) Figure 47. Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032) Figure 48. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 52. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 53. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032) Figure 58. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 63. UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 65. Chile Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Midgut Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Foregut Neuroendocrine Tumor
  • Hindgut Neuroendocrine Tumor
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Aurobindo Pharma
  • Curium Pharmaceuticals
  • Lantheus
  • Mundipharma
  • Bayer
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Midgut Neuroendocrine Tumor
  5. 1.2.3 Gastroenteropancreatic Neuroendocrine Tumor
  6. 1.2.4 Foregut Neuroendocrine Tumor
  7. 1.2.5 Hindgut Neuroendocrine Tumor
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Region
  15. 1.5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2021-2026)
  17. 1.5.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Dynamics
  1. 2.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends
  2. 2.2 Peptide Receptor Radionuclide Therapy (PRRT) Industry Drivers
  3. 2.3 Peptide Receptor Radionuclide Therapy (PRRT) Industry Opportunities and Challenges
  4. 2.4 Peptide Receptor Radionuclide Therapy (PRRT) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Company (2021-2026)
  2. 3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Key Company Head office and Area Served
  4. 3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Company, Product Type & Application
  5. 3.5 Global Peptide Receptor Radionuclide Therapy (PRRT) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptide Receptor Radionuclide Therapy (PRRT) Tier 1, Tier 2, and Tier 3
4 Peptide Receptor Radionuclide Therapy (PRRT) Market by Type
  1. 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2032)
  3. 4.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Type (2021-2032)
5 Peptide Receptor Radionuclide Therapy (PRRT) Market by Application
  1. 5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2032)
  3. 5.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Curium Pharmaceuticals
  8. 6.2.1 Curium Pharmaceuticals Company Information
  9. 6.2.2 Curium Pharmaceuticals Business Overview
  10. 6.2.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  12. 6.2.5 Curium Pharmaceuticals Recent Developments
  13. 6.3 Lantheus
  14. 6.3.1 Lantheus Company Information
  15. 6.3.2 Lantheus Business Overview
  16. 6.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  18. 6.3.5 Lantheus Recent Developments
  19. 6.4 Mundipharma
  20. 6.4.1 Mundipharma Company Information
  21. 6.4.2 Mundipharma Business Overview
  22. 6.4.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  24. 6.4.5 Mundipharma Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Portfolio
  36. 6.6.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032)
  2. 7.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  3. 7.2.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032)
  6. 7.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  7. 7.3.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032)
  10. 7.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
  11. 7.4.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032)
  2. 8.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  3. 8.2.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032)
  6. 8.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  7. 8.3.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032)
  10. 8.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
  11. 8.4.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032)
  2. 9.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  3. 9.2.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026)
  4. 9.2.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032)
  5. 9.2.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032)
  6. 9.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  7. 9.3.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026)
  8. 9.3.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032)
  9. 9.3.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032)
  2. 10.2 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  3. 10.2.1 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032)
  6. 10.3 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  7. 10.3.1 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032)
  10. 10.4 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
  11. 10.4.1 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst